NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / COVAXIN effectively neutralizes the Delta variant, top US body says
    India

    COVAXIN effectively neutralizes the Delta variant, top US body says

    COVAXIN effectively neutralizes the Delta variant, top US body says
    Written by Sagar
    Jun 30, 2021, 11:04 am 3 min read
    COVAXIN effectively neutralizes the Delta variant, top US body says
    A top US body has said COVAXIN is effective against the Delta variant of the coronavirus.

    Through the coronavirus pandemic, we have seen many variants emerge and cause fatal outbreaks across the globe. Presently, experts are raising concerns about the new Delta Plus variant. It is taking hold in India and other countries, and doctors say it may be able to evade prior immunity. Meanwhile, a top US body has said COVAXIN is effective against the Delta variant.

    What is the Delta Plus variant?

    The new variant was formed through an additional mutation (K417N) to the Delta variant (B.1.617.2), which drove India's deadly second wave of the pandemic. It was recently categorized as a "Variant of Concern" by the Indian government. A top genome sequencing authority in India said the variant has several dangerous characteristics, including increased transmissibility and stronger binding in receptors of lung cells.

    Will this variant affect vaccine efficacy?

    There is no data available yet to state the Delta Plus variant would affect the immunity developed from vaccination, said Dr. Tanu Singhal, Consultant, Paediatrics and Infectious Disease at Kokilaben Dhirubhai Ambani Hospital, Mumbai. "We don't have sufficient knowledge about the transmissibility or the virulence or the immune escape properties of this Delta Plus variant," Dr. Singhal told Hindustan Times.

    Can a recovered patient get re-infected with Delta Plus?

    "So far, reinfections have been few," said Dr. Singhal. Even in cases of reinfection, the disease is mostly mild and the patient doesn't require hospitalization, she informed. However, it is too early to say if that will be the case with Delta Plus variant as well, the doctor added. "We don't know how common that is going to be for reinfection with Delta Plus."

    Are there are any additional symptoms you should know about?

    "We do not have data so far to establish that the symptoms are milder or more severe as compared to the Delta variant," Dr. Singhal told HT. The most common symptoms of the coronavirus are fever, dry cough, fatigue, body aches, headache, anosmia, tastelessness, etc.

    Separately, study finds COVAXIN effective against Delta

    Separately, COVAXIN - India's only approved indigenous jab so far - is effective against both Alpha and Delta variants of the COVID-19, the United States' National Institute of Health (NIH) said. The NIH cited results of two studies where blood serum of COVAXIN recipients was tested against the said two variants. COVAXIN has been found 78% effective against symptomatic disease in phase three trials.

    India's coronavirus situation

    India had faced the world's worst coronavirus outbreak earlier this year, witnessing lakhs of cases and thousands of fatalities daily amid an overburdened healthcare infrastructure. The situation has since improved. In the past 24 hours, the country reported 45,951 fresh cases and 817 fatalities. 19% of the Indian population has received a COVID-19 vaccine shot while 4% has been fully inoculated.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Coronavirus
    COVID-19
    COVAXIN
    COVID-19 Vaccination

    Latest

    Happy birthday, Angad Bedi! Here are the stud's fitness secrets Fitness and Health
    How to redeem Free Fire MAX codes for February 6 Garena Free Fire MAX
    Powerful 7.8-magnitude earthquake jolts Turkey; 53 dead, 100+ buildings collapse Turkey
    Grammy Awards: Ricky Kej bags third Grammy, Beyoncé scripts history Grammy Awards

    Coronavirus

    COVID-19 outbreak has infected 80% of Chinese population China
    COVID-19: WHO urges travelers to mask up amid XBB.1.5 spread World Health Organization
    China: Hospitals cancel New Year holidays to meet patients' requirements China
    #NewsBytesExplainer: What's XBB.1.5, COVID-19 sub-variant triggering cases spike in US  COVID-19

    COVID-19

    Kerala: Man gets 3 life-terms for raping, impregnating minor daughter Kerala
    Amid global slowdown predictions, IMF calls India 'bright spot' International Monetary Fund
    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched Vaccine
    Have you heard about the travel trends for 2023 yet Travel And Tourism

    COVAXIN

    Bharat Biotech completes third-phase of intranasal COVID-19 vaccine trials United Kingdom
    Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension World Health Organization
    DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years Drugs Controller General of India
    COVAXIN likely to get approval for children above 2yrs: Report Drugs Controller General of India

    COVID-19 Vaccination

    Centre refutes reports on side-effects of COVID-19 vaccines Union Health Ministry
    Chinese residents hesitant of COVID-19 vaccine as cases rise: Reports China
    China may witness over 1 million COVID-19 deaths in 2023 China
    China administers over 1 million COVID-19 vaccine doses a day China

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023